Cycle threshold responses in SARS-COV2 PCR tests depend on the method by which the samples were obtained and require strict global standardization.


Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 11 01 2022
accepted: 01 02 2022
pubmed: 19 2 2022
medline: 3 8 2022
entrez: 18 2 2022
Statut: ppublish

Résumé

Since 2020, a SARS-COV2 epidemic has been raging worldwide. The cycle of the PCR test in which the virus is detected is called cycle threshold (CT). The method of obtaining the sample is not detailed in any published study and is based on general guidelines of the CDC. Our contention is that the manner in which the sample is obtained has a dramatic effect on CT values. For each person suspected of having Covid-19 who arrives at the emergency room, two swabs are taken in succession, one according to CDC guidelines and the other according to "Ziv" guidelines. The Ziv method sample collection guidelines determine the depth of penetration, the number of rotations of the swab, and their direction. Each double sample was sent for analysis. Analysis of the CT results of the sample to results methods and of the Seegene platform clearly found (p = 0.003 and p = 0.001, respectively) that more rigorous sample collection yielded lower CT values. The method of obtaining the samples had a dramatic effect on CT results. Any publication that includes CT results, and certainly studies that discuss CT kinetics, must describe in detail the method by which the samples were obtained. In places where it is also important to detect the onset of illness (airports, hospitals, schools, etc.), it is important to use the Ziv method to reduce the risk of false negatives.

Identifiants

pubmed: 35178676
doi: 10.1007/s15010-022-01772-4
pii: 10.1007/s15010-022-01772-4
pmc: PMC8853610
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

959-963

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Talanta. 2021 Apr 1;225:121977
pubmed: 33592725
Infect Dis Ther. 2020 Sep;9(3):573-586
pubmed: 32725536
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
Trials. 2020 Jun 08;21(1):498
pubmed: 32513289
J Occup Environ Med. 2020 Nov;62(11):889-891
pubmed: 32804748
Biologicals. 2011 Mar;39(2):89-93
pubmed: 21345697
J Infect Chemother. 2021 Jan;27(1):117-119
pubmed: 32994136
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061
pubmed: 32342252
J Pharm Anal. 2020 Apr;10(2):97-101
pubmed: 32292623

Auteurs

Shimon Edelstein (S)

Infectious Diseases Unit, Ziv Medical Center and Tel-Hai Academic Collage, Tel-Hai, Israel. shimone@ziv.gov.il.

Miriam Sudri (M)

Infectious Diseases Unit, Ziv Medical Center and Tel-Hai Academic Collage, Tel-Hai, Israel.

Shibli Tanous (S)

Infectious Diseases Unit, Ziv Medical Center and Tel-Hai Academic Collage, Tel-Hai, Israel.

Hila Ben Amram (H)

Clinical Microbiology Laboratory, Ziv Medical Center and Tel-Hai Academic Collage, Tel-Hai, Israel.

Adi Sharabi-Nov (A)

Statistical Unit, Ziv Medical Center and Tel-Hai Academic Collage, Tel-Hai, Israel.

Inna Rozenfeld (I)

Emergency Department, Ziv Medical Center, Safed, Israel.

Hedva Halal (H)

Emergency Department, Ziv Medical Center, Safed, Israel.

Salman Zarka (S)

Management, Ziv Medical Center, Safed, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH